KERTELSO Trademark

Trademark Overview

On Wednesday, August 14, 2019, a trademark application was filed for KERTELSO with the United States Patent and Trademark Office. The USPTO has given the KERTELSO trademark a serial number of 88579014. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 31, 2023. This trademark is owned by Ovid Therapeutics Inc.. The KERTELSO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
kertelso

General Information

Serial Number88579014
Word MarkKERTELSO
Filing DateWednesday, August 14, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 31, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 5, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of neurological developmental disorders; Pharmaceutical preparations for the treatment of neurological disorders
Translation of Words in MarkThe wording "KERTELSO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 29, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameOvid Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10001
Party NameOvid Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036

Trademark Events

Event DateEvent Description
Monday, July 31, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 31, 2023ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 9, 2023SOU EXTENSION 5 GRANTED
Tuesday, December 20, 2022SOU EXTENSION 5 FILED
Monday, January 9, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 20, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 29, 2022SOU EXTENSION 4 GRANTED
Wednesday, June 29, 2022SOU EXTENSION 4 FILED
Wednesday, June 29, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 20, 2021SOU EXTENSION 3 GRANTED
Monday, December 20, 2021SOU EXTENSION 3 FILED
Monday, December 20, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, June 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 28, 2021SOU EXTENSION 2 GRANTED
Monday, June 28, 2021SOU EXTENSION 2 FILED
Monday, June 28, 2021SOU TEAS EXTENSION RECEIVED
Thursday, December 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2020SOU EXTENSION 1 GRANTED
Tuesday, December 8, 2020SOU EXTENSION 1 FILED
Tuesday, December 8, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, June 30, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 5, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 5, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 15, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 30, 2020ASSIGNED TO LIE
Tuesday, March 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 23, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 23, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 23, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 8, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION E-MAILED
Tuesday, October 8, 2019NON-FINAL ACTION WRITTEN
Tuesday, October 8, 2019ASSIGNED TO EXAMINER
Thursday, August 29, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, August 17, 2019NEW APPLICATION ENTERED

Related Keywords

kertelso disorders neurological treatment pharmaceutical preparations developmental